A Study of AND017 to Evaluate Efficacy and Safety in Patients With Anemia Due to Non-Dialysis-Dependent Chronic Kidney Disease (NDD-CKD)

NCT07487727 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

240

Enrollment

INDUSTRY

Sponsor class

Conditions

Anemia Due to Chronic Kidney Disease

Interventions

DRUG: AND017
DRUG: ESA

Sponsor

Kind Pharmaceuticals LLC